Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
At close: Nov 16, 2026 · 4:00 PM EST

Elite Pharmaceuticals (ELTP) Return on Invested Capital [ROIC] (2009 - 2026)

Updated

Elite Pharmaceuticals' Return on Invested Capital [ROIC] was 27.58% in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 15.56 percentage points from 43.14% a year earlier and down 1.60 percentage points from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Return on Invested Capital [ROIC] (2009 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Return on Invested Capital [ROIC] at Elite Pharmaceuticals came in at 48.11%, up 16.56 percentage points from FY2025.

  • Return on Invested Capital [ROIC] has now increased for three consecutive fiscal years, with a five-year change of +48.11 percentage points (FY2021 to FY2026).
  • In earlier fiscal years, Return on Invested Capital [ROIC] was 31.55% in FY2025 (+9.08 pp), 22.47% in FY2024 (+11.24 pp), 11.23% in FY2023 (-11.55 pp) and 22.78% in FY2022 (+22.78 pp).
  • The fiscal Q2 2027 figure marks the lowest quarterly Return on Invested Capital [ROIC] since fiscal Q3 2025.
  • Compared with a year earlier, Return on Invested Capital [ROIC] was higher in six of the last eight quarters, with an average year-over-year change of +11.35 percentage points.
  • The best year-over-year quarter for Return on Invested Capital [ROIC] over five years was fiscal Q1 2026 (a gain of 47.78 percentage points); the worst was fiscal Q1 2027 (a drop of 38.79 percentage points).
  • Per Business Quant data, ELTP's Return on Invested Capital [ROIC] in the three fiscal quarters before Q2 2027 was 29.19% (Q1 2027), 42.17% (Q4 2026) and 53.59% (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 30.89%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 17.57%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 24.28%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 2.52%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 22.91%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 15.60%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -6.11%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 12.34%
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn 27.58%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 27.58%
Jun 30, 2026 29.19%
Mar 31, 2026 42.17%
Dec 31, 2025 53.59%
Sep 30, 2025 43.14%
Jun 30, 2025 67.98%
Mar 31, 2025 38.05%
Dec 31, 2024 25.12%
Sep 30, 2024 23.17%
Jun 30, 2024 20.19%
Mar 31, 2024 18.38%
Dec 31, 2023 0.00%
Sep 30, 2023 11.49%
Jun 30, 2023 10.94%
Mar 31, 2023 9.51%
Dec 31, 2022 11.21%
Sep 30, 2022 11.93%
Mar 31, 2022 0.00%
Dec 31, 2021 0.00%
Sep 30, 2021 0.00%
API Access

Elite Pharmaceuticals Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=ELTP&period=max&api_key=YOUR_API_KEY